HRTXHeron Therapeutics, Inc.

$153M

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M

Gross Profit

$2M67.3% margin

Operating Income

-$49M-1357.4% margin

Net Income

-$50M-1385.7% margin

EPS (Diluted)

$-1.00

QoQ Revenue Growth

+184.0%

Cash Flow

Operating Cash Flow

-$51M

Free Cash Flow

-$52M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$190M

Total Liabilities

$87M

Stockholders' Equity

$102M

Cash & Equivalents

$84M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$0	—
Gross Profit	$2M	-$16M	+115.2%
Operating Income	-$49M	-$33M	-48.0%
Net Income	-$50M	-$33M	-50.5%

HRTX Q1 2017 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena